Clinicopathological features predicting nodal metastasis of testicular seminoma: Results from 100 cases in a single institute

Urologia Internationalis

Volumn 77, Issue 1, 2006, Pages 64-68

  Sato, Akinori ^a,b   Ohigashi, Takashi ^a   Oya, Mototsugu ^a   Nakashima, Jun ^a   Marumo, Ken ^a   Murai, Masaru ^a  

^a KEIO UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Metastasis, nodal; Seminoma, testicular

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; IFOSFAMIDE; VINBLASTINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CONSULTATION; DISEASE SEVERITY; FOLLOW UP; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; ORCHIECTOMY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SEMINOMA; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 33745857365     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092938     Document Type: Article

References (11)

1. Classen J, Souchon R, Hehr T, Bamberg M: Treatment of early-stage testicular seminoma. J Cancer Res Clin Oncol 2001;127:475-481.
2. Tsumatani K, Ozono S, Momose H, Hirao Y, Okajima E: Clinical study of testicular cancer. Hinyokika Kiyo 1996;42:943-950.
3. Sundstrom J, Salminen E, Nurmi M, Toppari J, Pollanen P, Pelliniemi LJ, Huhtala S, Rajala P, Laato M: Management of testicular cancer. Scand J Urol Nephrol 2001;35:21-25.
4. Ziegler M: Pathogenese, Diagnostik und Therapie von Hodentumoren. Urologe A 1992;31:W25-W33.
5. Milosevic MF, Gospodarowicz M, Warde P: Management of testicular seminoma. Semin Surg Oncol 1999;17:240-249.
6. Richie JP: Neoplasm of the testis; in Walsh PC, et al (eds): Campbell's Urology, ed 7. Philadelphia, Saunders, 1998, pp 2411-2452.
7. Lawton AJ, Mead GM: Staging and prognostic factors in testicular cancer. Semin Surg Oncol 1999;17:223-229.
8. Tsushima T, Kumon H, Ohmori H, Furukawa Y, Tanaka H, Nakahara M, Usui T, Yamamoto M, Naito K, Hirakawa S, Miyagawa I, Fujita K, Takenaka I, Kanayama H, Kagawa S, Yokoyama M, Takeuchi M, Yamashita M, Shuin T, Sumiyoshi Y, Takigawa H: Clinical statistics of stage I testicular tumor. Nippon Hinyokika Gakkai Zasshi 1999;90:624-632.
9. Tomomasa H, Shimizu H, Sato S, Adachi Y, Ashizawa Y, Kamiyama Y, Okano Y, Sato M, Yoshii T, Iizumi T, Umeda T, Yazaki T: Clinical study of testicular germ cell tumors. Hinyokika Kiyo 2001;47:389-395.
10. Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK, de Wit R, Aass N, Graham JD, Coleman R, Kirk SJ, Stenning SP, MRC TE19 collaborators, EORTC 30982 collaborators: Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 2005;366:293-300.
11. Von der Maase H: Editorial: do we have a new standard of treatment for patients with seminoma stage IIA and stage IIB? Radiother Oncol 2001;59:1-3.